Analystreport

Enanta Pharmaceuticals Inc (NASDAQ: ENTA) was upgraded by analysts at Robert W. Baird from a "neutral" rating to an "outperform" rating.

Enanta Pharmaceuticals, Inc.  (ENTA) 
Last enanta pharmaceuticals, inc. earnings: 2/6 04:00 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.enanta.com/investor-overview